Brian Kuhn serves as Executive at CHEMOKINE THERAPEUTICS CORP, where they oversee executive responsibilities. Since joining the company, Brian Kuhn has executed 1 insider transactions totaling $60.0K, demonstrating a bullish approach to their equity position. Their most recent transaction on Feb 7, 2008 involved purchasing 300,000 shares valued at $60.0K.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Feb 7, 2008 | CHKT | $60.0K | Purchase | 300,000 | $0.20 | Discretionary |
Brian Kuhn currently holds 827,000 shares of CHEMOKINE THERAPEUTICS CORP (CHKT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Brian Kuhn has been a net buyer of CHKT stock. They have purchased $60.0K and sold $0 worth of shares.
Brian Kuhn's most recent insider trade was on Feb 7, 2008, when they purchased 300,000 shares at $0.20 per share.
Get notified when new Form 4 filings are submitted